Literature DB >> 976464

Limitations of the direct linear plot in evaluation of drug-protein binding parameters.

N Kolassa, K Turnheim.   

Abstract

The applicability of the direct linear plot is compared with that of the Scatchard plot for the estimation of protein binding parameters. Only, if one class of binding sites exists in the system tested, binding parameters may be estimated by use of the direct linear plot. On the other hand the Scatchard plot also provides estimates in systems with more that one class of binding sites.

Mesh:

Year:  1976        PMID: 976464     DOI: 10.1007/BF01953138

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  DETERMINATION OF EQUILIBRIUM CONSTANTS AND MAXIMUM BINDING CAPACITIES IN COMPLEX IN VITRO SYSTEMS. I. THE MAMMILLARY SYSTEM.

Authors:  H E HART
Journal:  Bull Math Biophys       Date:  1965-03

2.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

3.  An unbiased method for estimating binding parameters in a non-cooperative binding process.

Authors:  J H Perrin; J J Vallner; S Wold
Journal:  Biochim Biophys Acta       Date:  1974-12-18

4.  The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters.

Authors:  R Eisenthal; A Cornish-Bowden
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

5.  Statistical considerations in the estimation of enzyme kinetic parameters by the direct linear plot andother methods.

Authors:  A Cornish-Bowden; R Eisenthal
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

Review 6.  The binding of drugs by plasma proteins.

Authors:  M C Meyer; D E Guttman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

7.  Properties of graphical representations of multiple classes of binding sites.

Authors:  I M Klotz; D L Hunston
Journal:  Biochemistry       Date:  1971-08-03       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.